How big is the North America Colorectal Cancer Screening Market?

The North America Colorectal Cancer Screening Market size is expected to reach USD 7.15 billion in 2024 and grow at a CAGR of 6.70% to reach USD 9.89 billion by 2029. Read More

What is the current North America Colorectal Cancer Screening Market size?

In 2024, the North America Colorectal Cancer Screening Market size is expected to reach USD 7.15 billion. Read More

Who are the key players in North America Colorectal Cancer Screening Market?

Abbott Laboratories, Epigenomics Inc., Exact Sciences Corporation, Clinical Genomics Technologies Pty Ltd. and Hemosure Inc. are the major companies operating in the North America Colorectal Cancer Screening Market. Read More

What years does this North America Colorectal Cancer Screening Market cover, and what was the market size in 2023?

In 2023, the North America Colorectal Cancer Screening Market size was estimated at USD 6.67 billion. The report covers the North America Colorectal Cancer Screening Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Colorectal Cancer Screening Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

North America Colorectal Cancer Screening Market Share

Statistics for the 2023 & 2024 North America Colorectal Cancer Screening market share, created by Mordor Intelligence™ Industry Reports. North America Colorectal Cancer Screening share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of North America Colorectal Cancer Screening Industry

The North American colorectal cancer screening market is fragmented due to the presence of many small and large market players. These market players are involved in various strategic activities such as agreements, partnerships, and developments to increase the product portfolio of the companies in the region. Some key North American colorectal cancer screening market players are Abbott Laboratories, Epigenomics Inc., Exact Sciences Corporation, F. Hoffmann-La Roche AG, Novigenix SA, Siemens Healthineers, and Sysmex Corporation.